Pfizer expands Rocky Mount injectable facility to $190 million

Pfizer is continuing construction at its Rocky Mount, North Carolina site, increasing the scope of its sterile injectable manufacturing facility expansion from $159 million to $190 million, adding a 65,000-square-foot adjacent facility. No new jobs are expected.

“The original plan for the new sterile injectable manufacturing facility was to create new capacity to shift product volumes from some of our aging lines in the existing sterile manufacturing facility to the new facility.”biospace.com

• 1 source
• biospace.comPfizer Continues $190 Million Expansion Plans in North Carolina - BioSpaceAnnalee ArmstrongFeb 21, 2017

Summarized from public sources; check the original articles before acting on it.